Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Other Non Operating Income: 2013-2025

Historic Other Non Operating Income for Fortress Biotech (FBIO) over the last 4 years, with Sep 2025 value amounting to $17.7 million.

  • Fortress Biotech's Other Non Operating Income rose 1550.05% to $17.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.6 million, marking a year-over-year increase of 80018.18%. This contributed to the annual value of $1.3 million for FY2024, which is 138.73% up from last year.
  • Latest data reveals that Fortress Biotech reported Other Non Operating Income of $17.7 million as of Q3 2025, which was up 28,603.23% from -$62,000 recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Other Non Operating Income registered a high of $17.7 million during Q3 2025, and its lowest value of -$1.4 million during Q4 2023.
  • For the 3-year period, Fortress Biotech's Other Non Operating Income averaged around $1.7 million, with its median value being $282,000 (2024).
  • Its Other Non Operating Income has fluctuated over the past 5 years, first plummeted by 338.80% in 2023, then soared by 1,550.05% in 2025.
  • Over the past 4 years, Fortress Biotech's Other Non Operating Income (Quarterly) stood at $567,000 in 2022, then crashed by 338.80% to -$1.4 million in 2023, then spiked by 98.82% to -$16,000 in 2024, then surged by 1,550.05% to $17.7 million in 2025.
  • Its Other Non Operating Income was $17.7 million in Q3 2025, compared to -$62,000 in Q2 2025 and -$12,000 in Q1 2025.